02546oam 2200493 450 991082404890332120170523091546.00-12-387818-7(OCoLC)841488683(MiFhGG)GVRL8DNW(EXLCZ)99267000000035406820140531d2013 uy 0engurun|---uuuuatxtrdacontentcrdamediacrrdacarrierDrug-induced liver disease /edited by Neil Kaplowitz, MD, Professor of Medicine and Director, Research Center for Liver Diseases, Chief, Division of GI-Liver, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA, Laurie D. DeLeve, MD, PhD, Professor of Medicine, Division of Gastrointestinal and Liver Diseases, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA3rd ed.London Elsevier2013London :Academic Press,2013.1 online resource (xxiv, 746 pages) illustrations (some color)Gale eBooksDescription based upon print version of record.0-12-387817-9 Includes bibliographical references and index.pt. 1. Mechanisms of liver injury -- pt. 2. Diagnosis and management -- pt. 3. Hepatotoxicity of specific drugs -- pt. 4. Future directions.This field has shown tremendous growth in recent years, primarily due to the recognition that drug-induced liver disease is the most common cause of liver failure and one of the major contributors to the withdrawal of drugs developed by the pharmaceutical industry. Drug-Induced Liver Disease, 3rd edition is a comprehensive reference that covers mechanisms of injury, diagnosis and management, major hepatotoxins, regulatory perspectives and much more. Written by highly respected authorities, this new edition is an updated and definitive reference for clinicians and scientists in acHepatotoxicologyLiverEffect of drugs onDrugsSide effectsHepatotoxicology.LiverEffect of drugs on.DrugsSide effects.616.3/6Kaplowitz Neil1694549Kaplowitz NeilDeLeve Laurie D.1955-MiFhGGMiFhGGBOOK9910824048903321Drug-induced liver disease4073191UNINA